The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer.
 
Yuan Yuan
Consulting or Advisory Role - AstraZeneca; Diiachi; Genentech; Merck; Stemline Therapeutics; Stemline Therapeutics
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Gilead Sciences; Merck
Research Funding - Genentech; Imugene; Merck; Novartis; Pfizer
Expert Testimony - Novartis
 
Jin Sun Bitar
Research Funding - Bristol Myers Squibb Foundation
 
MaLia Walker
No Relationships to Disclose
 
David Lin
No Relationships to Disclose
 
January Lee
No Relationships to Disclose
 
So Yung Choi
No Relationships to Disclose
 
Stephen Shiao
Research Funding - Merck
 
Mourad Tighiouart
Leadership - Da Zen Theranostics Inc
Stock and Other Ownership Interests - Da Zen Theranostics
Consulting or Advisory Role - Za Zen Theranostics Inc
 
Paul Frankel
Stock and Other Ownership Interests - Geron
Consulting or Advisory Role - Johnson & Johnson/Janssen
 
Peter Lee
No Relationships to Disclose